Shareable Research Card

EVOME MEDICAL TECHNOLOGIES INC. Assets, Current

This metric view shows EVOME MEDICAL TECHNOLOGIES INC. assets, current history from SEC company facts.

Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.

Context
Latest reported period: Q4 2023
Latest reported value
CA$21,003,490

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.

Return Loop

Why revisit this metric view

This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.

Latest source-backed update
Latest period end 31 Dec 2023
Why come back
Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
  • Current latest reported period: Q4 2023.
  • Latest reported value on this page: CA$21,003,490.
  • Save this filer if you want to compare the next reported value with this history.

Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.

Latest update

Latest update for Assets, Current

New fact period available

Latest reported assets, current: CA$21,003,490. Open the source-backed page to compare this metric with the newest filing-backed context.

Update date

31 Dec 2023

Page type

Metric history

Latest period

Q4 2023

SEC-backed company facts were refreshed from filings filed on 16 Apr 2024.

Benchmark Context

How Assets, Current compares with peers

EVOME MEDICAL TECHNOLOGIES INC. sits in the bottom quarter of the current assets, current sample.

Compared with

Compared with 20 companies reporting assets, current in CAD. This keeps the comparison on the same metric and unit family.

Why this is notable

This is about 0x the current sample midpoint. Assets, Current is up about 27% versus the comparable prior period.

  • Visible rows currently span reported period ends from 31 Dec 2017 to 31 May 2026.
  • Nearby companies in this sample: NexMetals Mining Corp. and SRX Global Inc..
  • Current sample position: rank #16 of 20 comparable companies.
  • Peer rows use the latest valid value per company for this exact metric and compatible units.

Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Financial Metric Page

EVOME MEDICAL TECHNOLOGIES INC.: Assets, Current

Latest period: Q4 2023. Period end: 31 Dec 2023. Units: CAD. Frequency: quarterly.

Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

What this metric tells you

  • Shows reported assets, current over 28 Feb 2021 - 31 Dec 2023.
  • Includes year-over-year change points to highlight acceleration or slowdown.
  • Built from 12 SEC fact rows for this metric and issuer.

How to read this chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use quarterly sequence to compare like-for-like periods.
  • Use YoY change bars to separate growth from contraction across matching periods.

Compare This Metric Across Companies

Compare latest available Assets, Current levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

EVOME MEDICAL TECHNOLOGIES INC. appears at rank #16 in the latest comparison sample.

Rank Company Latest value Report period Next step
1 ENBRIDGE INC (enb) CA$18,859,000,000 Instant - 31 Mar 2026 Open ENBRIDGE INC Assets, Current
2 IMPERIAL OIL LTD (imo) CA$11,519,000,000 Instant - 31 Mar 2026 Open IMPERIAL OIL LTD Assets, Current
3 EMERA INC (ema) CA$4,389,000,000 Instant - 31 Dec 2025 Open EMERA INC Assets, Current
4 Fortis Inc. (fts) CA$3,805,000,000 Instant - 31 Dec 2025 Open Fortis Inc. Assets, Current
5 CANADIAN PACIFIC KANSAS CITY LTD/CN (cp) CA$3,404,000,000 Instant - 31 Mar 2026 Open CANADIAN PACIFIC KANSAS CITY LTD/CN Assets, Current
6 CANADIAN NATIONAL RAILWAY CO (cni) CA$2,471,000,000 Instant - 31 Dec 2025 Open CANADIAN NATIONAL RAILWAY CO Assets, Current

Metric Details

Metric identity Names, identifiers, and filing context for this profile. 1 identity field
Taxonomy
us-gaap
Metric coverage 3 source fields
Units tracked
CAD
History range
28 Feb 2021 - 31 Dec 2023
Freshness: From parsed SEC XBRL facts on this page
Facts on this page
12
Source: SEC company facts API
How to read it 1 detail
Metric definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Source evidence Original filing metadata and source links for verification. 1 source field
SEC metric endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Assets, Current, Quarterly (CAD)
Assets, Current, YoY Quarterly Change (%)

EVOME MEDICAL TECHNOLOGIES INC. Quarterly Assets, Current (CAD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2023 CA$21,003,490 +CA$4,402,636 +27% 31 Dec 2023 10-K 16 Apr 2024 2023 FY
Q3 2023 CA$25,374,270 +CA$2,056,941 +8.8% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 CA$27,538,765 +CA$6,653,284 +32% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 CA$18,147,074 -CA$1,887,927 -9.4% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 CA$16,600,854 +CA$894,241 +5.7% 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 CA$23,317,329 +CA$3,512,816 +18% 31 Aug 2022 10-Q 17 Oct 2022 2022 Q2
Q2 2022 CA$20,885,481 +CA$551,834 +2.7% 31 May 2022 10-Q 15 Jul 2022 2023 Q1
Q1 2022 CA$20,035,001 +CA$6,905,110 +53% 28 Feb 2022 10-KT 03 Apr 2023 2022 FY
Q4 2021 CA$15,706,613 31 Dec 2021 10-KT 03 Apr 2023 2022 FY
Q3 2021 CA$19,804,513 31 Aug 2021 10-Q 15 Oct 2021 2022 Q2
Q2 2021 CA$20,333,647 31 May 2021 10-Q/A 02 Aug 2021 2022 Q1
Q1 2021 CA$13,129,891 28 Feb 2021 10-K 31 May 2022 2022 FY
* marks a reported value that did not pass the local value check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .